Edwards Lifesciences Corporation Peer Comparison
| Metric | Value | Ranking | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $41.0 Billion | 5/10 | ABT $174.1B |
SYK $140.2B |
BSX $123.5B |
MDT $115.4B |
EW $41.0B |
DXCM $27.6B |
ZBH $21.4B |
ALGN $17.1B |
PODD $16.2B |
TNDM $2.9B |
| Gross Margin | 79% | 1/10 | EW 79% |
ALGN 71% |
PODD 68% |
BSX 63% |
DXCM 62% |
ZBH 61% |
SYK 61% |
MDT 60% |
ABT 56% |
TNDM 51% |
| Profit Margin | 26% | 2/10 | PODD 39% |
EW 26% |
SYK 15% |
DXCM 14% |
MDT 13% |
ZBH 13% |
ABT 12% |
ALGN 9% |
BSX 8% |
TNDM -14% |
| EBITDA margin | 29% | 2/10 | ZBH 30% |
EW 29% |
MDT 27% |
BSX 26% |
SYK 26% |
DXCM 21% |
ALGN 21% |
ABT 15% |
PODD 15% |
TNDM -12% |
| Quarterly Revenue | $1.4 Billion | 6/10 | ABT $10.0B |
MDT $7.9B |
SYK $5.4B |
BSX $4.1B |
ZBH $1.9B |
EW $1.4B |
ALGN $1.0B |
DXCM $1.0B |
PODD $488.5M |
TNDM $221.9M |
| Quarterly Earnings | $366.3 Million | 4/10 | ABT $1.2B |
MDT $1.0B |
SYK $825.0M |
EW $366.3M |
BSX $324.0M |
ZBH $242.8M |
PODD $188.6M |
DXCM $143.5M |
ALGN $96.6M |
TNDM -$30.8M |
| Quarterly Free Cash Flow | $286.1 Million | 5/10 | BSX $658.0M |
ABT $627.0M |
SYK $481.0M |
MDT $466.0M |
EW $286.1M |
ZBH $264.0M |
DXCM $213.3M |
ALGN $106.4M |
PODD $71.6M |
TNDM -$11.7M |
| Trailing 4 Quarters Revenue | $6.0 Billion | 5/10 | ABT $40.3B |
MDT $32.6B |
SYK $21.4B |
BSX $15.2B |
EW $6.0B |
ZBH $5.8B |
ALGN $3.9B |
DXCM $3.9B |
PODD $1.9B |
TNDM $796.0M |
| Trailing 4 Quarters Earnings | $1.5 Billion | 5/10 | ABT $10.0B |
MDT $7.9B |
SYK $5.4B |
BSX $4.1B |
ZBH $1.9B |
EW $1.4B |
ALGN $1.0B |
DXCM $1.0B |
PODD $488.5M |
TNDM $221.9M |
| Quarterly Earnings Growth | 19% | 5/10 | PODD 591% |
MDT 32% |
DXCM 24% |
BSX 20% |
EW 19% |
ZBH 16% |
TNDM 14% |
SYK 12% |
ABT -7% |
ALGN -14% |
| Annual Earnings Growth | 11% | 8/10 | PODD 301% |
DXCM 155% |
TNDM 66% |
BSX 51% |
SYK 37% |
ABT 27% |
ALGN 19% |
EW 11% |
MDT -9% |
ZBH -36% |
| Quarterly Revenue Growth | -9% | 10/10 | PODD 23% |
DXCM 15% |
BSX 14% |
TNDM 13% |
SYK 9% |
ZBH 4% |
MDT 3% |
ALGN 3% |
ABT 2% |
EW -9% |
| Annual Revenue Growth | 2% | 7/10 | DXCM 27% |
PODD 27% |
TNDM 13% |
BSX 11% |
SYK 11% |
ALGN 3% |
EW 2% |
ABT 1% |
MDT -2% |
ZBH -22% |
| Cash On Hand | $1.6 Billion | 4/10 | ABT $6.3B |
BSX $3.0B |
SYK $1.9B |
EW $1.6B |
MDT $1.3B |
DXCM $939.2M |
ALGN $761.4M |
PODD $715.5M |
ZBH $420.1M |
TNDM $47.7M |
| Short Term Debt | $21.5 Million | 10/10 | SYK $2.2B |
ABT $2.0B |
ZBH $1.9B |
BSX $1.6B |
MDT $1.6B |
TNDM $58.3M |
PODD $37.9M |
ALGN $30.8M |
DXCM $21.6M |
EW $21.5M |
| Long Term Debt | $597.3 Million | 8/10 | MDT $26.3B |
ABT $12.6B |
SYK $10.1B |
BSX $9.0B |
ZBH $4.0B |
DXCM $2.4B |
PODD $1.4B |
EW $597.3M |
TNDM $307.4M |
ALGN $98.3M |
| PE | 27.86 | 9/10 | BSX 67.64 |
DXCM 41.35 |
PODD 40.88 |
SYK 40.65 |
ALGN 38.24 |
ZBH 37.04 |
ABT 30.92 |
MDT 29.38 |
EW 27.86 |
TNDM -1.00 |
| PS | 6.84 | 4/10 | PODD 8.63 |
BSX 8.11 |
DXCM 7.01 |
EW 6.84 |
SYK 6.55 |
ALGN 4.34 |
ABT 4.32 |
ZBH 3.71 |
TNDM 3.60 |
MDT 3.54 |
| PB | 5.47 | 6/10 | PODD 16.18 |
TNDM 12.25 |
DXCM 11.33 |
SYK 7.09 |
BSX 5.99 |
EW 5.47 |
ALGN 4.55 |
ABT 4.46 |
MDT 2.40 |
ZBH 1.68 |
| PC | 24.90 | 8/10 | MDT 88.04 |
SYK 74.79 |
TNDM 60.06 |
ZBH 50.97 |
BSX 41.32 |
DXCM 29.36 |
ABT 27.70 |
EW 24.90 |
PODD 22.58 |
ALGN 22.45 |
| Liabilities to Equity | 0.35 | 10/10 | TNDM 3.01 |
PODD 1.89 |
DXCM 1.79 |
SYK 0.98 |
MDT 0.87 |
ABT 0.86 |
BSX 0.81 |
ZBH 0.69 |
ALGN 0.64 |
EW 0.35 |
| ROA | 0.15 | 1/10 | EW 15% | PODD 14% | DXCM 10% | SYK 9% | ABT 8% | ALGN 7% | BSX 5% | MDT 4% | ZBH 3% | TNDM -15% |
| ROE | 0.20 | 3/10 | PODD 40% |
DXCM 27% |
EW 20% |
SYK 17% |
ABT 15% |
ALGN 12% |
BSX 9% |
MDT 8% |
ZBH 5% |
TNDM -58% |
| Current Ratio | 3.89 | 1/10 | EW 3.89 |
ALGN 2.57 |
ZBH 2.45 |
BSX 2.25 |
ABT 2.17 |
MDT 2.16 |
SYK 2.02 |
DXCM 1.56 |
PODD 1.53 |
TNDM 1.33 |
| Quick Ratio | 0.77 | 1/10 | BSX 67.64 |
DXCM 41.35 |
PODD 40.88 |
SYK 40.65 |
ALGN 38.24 |
ZBH 37.04 |
ABT 30.92 |
MDT 29.38 |
EW 27.86 |
TNDM -1.00 |
| Long Term Debt to Equity | 0.08 | 9/10 | PODD} 1.36 |
TNDM} 1.31 |
DXCM} 1.00 |
MDT} 0.55 |
SYK} 0.51 |
BSX} 0.44 |
ABT} 0.32 |
ZBH} 0.31 |
EW} 0.08 |
ALGN} 0.03 |
| Debt to Equity | 0.09 | 9/10 | TNDM 2.04 |
PODD 1.40 |
DXCM 1.07 |
SYK 0.64 |
MDT 0.58 |
BSX 0.54 |
ZBH 0.46 |
ABT 0.38 |
EW 0.09 |
ALGN 0.03 |
| Burn Rate | -4.89 | 6/10 | SYK 13.43 |
BSX 6.94 |
MDT 3.30 |
ZBH 1.09 |
TNDM 0.83 |
EW -4.89 |
PODD -5.74 |
ALGN -8.96 |
DXCM -23.14 |
ABT -28.63 |
| Cash to Cap | 0.04 | 1/10 | EW 0.04 |
ABT 0.04 |
PODD 0.04 |
ALGN 0.04 |
DXCM 0.03 |
BSX 0.02 |
ZBH 0.02 |
TNDM 0.02 |
MDT 0.01 |
SYK 0.01 |
| CCR | 0.78 | 5/10 | BSX 2.03 |
DXCM 1.49 |
ALGN 1.10 |
ZBH 1.09 |
EW 0.78 |
SYK 0.58 |
ABT 0.51 |
MDT 0.45 |
TNDM 0.38 |
PODD 0.38 |
| EV to EBITDA | 99.15 | 6/10 | PODD} 228.19 |
DXCM} 139.14 |
ABT} 125.78 |
BSX} 124.20 |
SYK} 106.66 |
EW} 99.15 |
ALGN} 76.81 |
MDT} 67.54 |
ZBH} 46.36 |
TNDM} -123.53 |
| EV to Revenue | 6.68 | 5/10 | PODD 8.99 |
BSX 8.63 |
DXCM 7.43 |
SYK 7.06 |
EW 6.68 |
ZBH 4.65 |
ABT 4.52 |
MDT 4.36 |
ALGN 4.18 |
TNDM 4.14 |